Clinical Trials Sponsored by Prexton Therapeutics

Total 6346 results

Prexton Therapeutics

Withdrawn

Study to Evaluate the Efficacy, Safety, and Tolerability of PXT002331 (Foliglurax) in Reducing Levodopa-Induced Dyskinesia and Wearing OFF in Subjects With Parkinson's Disease Experiencing Motor Complications of Levodopa Therapy (ATTUNED) (ATTUNED)

Parkinson Disease
Prexton Therapeutics

Completed

Study to Evaluate the Efficacy, Safety and Tolerability of PXT002331 (Foliglurax) in Reducing Motor Complications of Levodopa Therapy in Parkinson Disease's Patients (AMBLED)

Parkinson Disease

France, Italy, Spain, Germany, United Kingdom, Austria
Prexton Therapeutics

Completed

A Phase I, Double Blind, Placebo Controlled, First in Human, Single and Multiple Ascending Oral Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Male and Female Subjects

Parkinson's Disease

United Kingdom
PreDxion Bio, Inc.

Unknown

Feasibility Study of MicroKine Dx System in Critically-ill Pediatric Patients.

Multiple Organ Failure
Proton Collaborative Group

Recruiting

Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

Prostate Cancer

United States
Proton Collaborative Group

Active, not recruiting

Study of Hypo-fractionated Proton Radiation for Low Risk Prostate Cancer

Prostate Cancer

United States
Proton Collaborative Group

Recruiting

Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy (COMPRO)

Breast Cancer

United States
Proton Collaborative Group

Recruiting

Registry Study for Radiation Therapy Outcomes

Neoplasms

United States
Proton Collaborative Group

Active, not recruiting

Proton Radiation for Stage II/III Breast Cancer

Breast Cancer | Breast Neoplasm | Breast Tumor | Cancer of the Breast

United States
Proton Collaborative Group

Terminated

External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer

Prostate Cancer

United States
Proton Collaborative Group

Recruiting

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

Breast Cancer | Breast Neoplasm | Breast Tumor | Cancer of the Breast

United States
Proton Collaborative Group

Active, not recruiting

A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer

Lung Neoplasms

United States
Ranok Therapeutics (Hangzhou) Co., Ltd.

Recruiting

A Study of RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1)

Advanced Solid Tumor | DLBCL

United States
Massachusetts General Hospital
The Hilda and Preston Davis Foundation

Completed

Association Between Attention Deficit Hyperactivity Disorder and Bulimia Nervosa in Outpatients With Eating Disorders

Bulimia Nervosa | ADHD | Eating Disorders
The New York Proton Center

Recruiting

Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors (ReRT)

Breast Cancer | Head and Neck Cancer | Gynecologic Cancer | Prostate Cancer | Thoracic Cancer | CNS Cancer | GI Cancer

United States
Johns Hopkins University
The Hilda and Preston Davis Foundation

Completed

Meal-Based Exposure and Response Prevention in Anorexia Nervosa

Anorexia Nervosa

United States
Children's Hospital of Philadelphia
The Hilda & Preston Davis Foundation

Completed

Cognitive Remediation Therapy for Adolescents With Anorexia Nervosa

Anorexia Nervosa

United States
Akebia Therapeutics
Cyclerion Therapeutics

Completed

A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria

Type 2 Diabetes Mellitus With Diabetic Nephropathy

United States
Akebia Therapeutics
Cyclerion Therapeutics

Completed

A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) (CAPACITY-HFpEF)

Heart Failure With Preserved Ejection Fraction

United States, Canada
The New York Proton Center

Recruiting

Phase II Study of Pencil Beam Scanning Proton Stereotactic Body Radiation Therapy for Prostate Cancer

Prostate Cancer

United States
Marc Breton

Completed

Exercise-Induced Hypoglycemia Prevention in Adults With Type 1 Diabetes Using an Artificial Pancreas

Hypoglycemia | Type 1 Diabetes Mellitus

United States
The New York Proton Center

Recruiting

Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer (PGHD)

Thoracic Cancer

United States
CRISPR Therapeutics AG

Recruiting

A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors

Clear Cell Renal Cell Carcinoma | Pancreatic Adenocarcinoma | Cervical Carcinoma | Malignant Pleural Mesothelioma | Esophageal Carcinoma

United States
CRISPR Therapeutics AG

Active, not recruiting

A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory T or B Cell Malignancies (COBALT-LYM)

T Cell Lymphoma

United States, Australia, Canada
CRISPR Therapeutics AG

Active, not recruiting

A Safety and Efficacy Study Evaluating CTX110 in Subjects With Relapsed or Refractory B-Cell Malignancies (CARBON)

B-cell Lymphoma | Non-Hodgkin Lymphoma | B-cell Malignancy | Adult B Cell ALL

United States, Spain, Canada, France, Germany, Australia
Bacainn Therapeutics, Inc.

Completed

A Phase 1, Single-Ascending-Dose Study of BT051 in Healthy Subjects

Healthy Volunteers

United States
Celsus Therapeutics PLC

Terminated

Double-Blind, Trial to Evaluate the Safety and Efficacy of MRX-6 Cream 2% (C012013)

Atopic Dermatitis

Israel
Shanghai Proton and Heavy Ion Center

Recruiting

Prospective Study of Particle Radiotherapy for Breast Cancer With Different Arm Position

Breast Cancer

China
Shanghai Proton and Heavy Ion Center

Recruiting

A Prospective Phase II Study for Adjuvant Hypofractionated Intensity-modulated Proton Radiotherapy for Post Operative Breast Cancer With Implantation Reconstruction

Breast Cancer

China
Shanghai Proton and Heavy Ion Center

Not yet recruiting

Individualized Carbon-Ion Radiotherapy for Patients With Locally Recurrent Nasopharyngeal Carcinoma

Locally Recurrent Nasopharyngeal Carcinoma

China
Shanghai Proton and Heavy Ion Center

Completed

Proton and Carbon Ion Radiotherapy for Locally Advanced Pancreatic Cancer

Pancreatic Carcinoma

China
Shanghai Proton and Heavy Ion Center

Terminated

Trial Evaluating Carbon Ion Radiotherapy With Concurrent Chemotherapy for Locally Recurrent Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Shanghai Proton and Heavy Ion Center

Unknown

Trail Evaluating Particle Therapy With or Without Apatinib for H&N Adenoid Cystic Carcinoma

Adenoid Cystic Carcinoma

China
Eikon Therapeutics
Impact Therapeutics, Inc.

Recruiting

A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors

Advanced Solid Tumor

Australia, United States
APRINOIA Therapeutics, LLC

Active, not recruiting

A First-in-Human Study to Assess Single Doses of APNmAb005 in Healthy Participants

Alzheimer Disease | Tauopathies | Healthy Volunteers

United States
CRISPR Therapeutics AG

Active, not recruiting

A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory Renal Cell Carcinoma (COBALT-RCC)

Renal Cell Carcinoma

United States, Australia, Canada, Netherlands
CRISPR Therapeutics AG

Recruiting

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

Follicular Lymphoma | B-cell Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Non-Hodgkin Lymphoma | B-cell Malignancy | Large B-cell Lymphoma | Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

United States
CRISPR Therapeutics AG

Enrolling by invitation

A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

Hematologic Malignancy | Solid Malignancy

United States
CRISPR Therapeutics AG

Active, not recruiting

A Safety and Efficacy Study Evaluating CTX120 in Subjects With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United States, Spain, Australia, Canada
APRINOIA Therapeutics, LLC

Active, not recruiting

Evaluation of [18F]APN-1607 PET Uptake in Alzheimer's Disease Patients Compared With Healthy Subjects

Healthy Volunteers | Alzheimer's Disease | Mild Cognitive Impairment Due to Alzheimer's Disease

United States
Brenton Alexander

Not yet recruiting

Effectiveness of iPACK on Postoperative Pain From Hamstring Autograft Following ACL Repair

Pain, Postoperative | Anesthesia, Local | Opioid Use | ACL Injury
Shanghai Proton and Heavy Ion Center

Recruiting

Carbon Ion Radiotherapy for Recurrent Pancreatic Cancer Post Surgery

Pancreatic Carcinoma

China
Shanghai Proton and Heavy Ion Center

Recruiting

A Dose Escalation Study of Proton and Carbon Ion Irradiation for HER2 Positive and Triple Negative Breast Cancer

Triple Negative Breast Cancer | HER2-positive Breast Cancer

China
Shanghai Proton and Heavy Ion Center

Recruiting

Carbon Ion Therapy for Peripheral Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Shanghai Proton and Heavy Ion Center

Recruiting

Ablative Carbon Ion Radiotherapy With Pencil Beam Scanning for Locally Advanced Unresectable Pancreatic Cancer

Pancreatic Cancer Non-resectable

China
Shanghai Proton and Heavy Ion Center

Recruiting

Functional Image-Guided Carbon Ion Irradiation With Simultaneous Integrated Boost for Prostate Cancer

Localized Prostate Cancer

China
Shanghai Proton and Heavy Ion Center

Recruiting

12 Fractions Carbon Ion Radiotherapy for Localized Prostate Cancer

Prostate Cancer | Radiotherapy

China
Shanghai Proton and Heavy Ion Center

Recruiting

Carbon Ion Radiotherapy for the Treatment of Localized Prostate Cancer

Prostate Carcinoma

China
Shanghai Proton and Heavy Ion Center

Terminated

Carbon Ion Radiotherapy for the Treatment of Chinese Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Shanghai Proton and Heavy Ion Center

Completed

Proton and Carbon Ion Radiotherapy for Cervical Cancer

Cervical Cancer

Clinical Trials Sponsored by Prexton Therapeutics

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malawi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations